Trailing-twelve-month (TTM) revenue is $1.42 Million. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $361,935 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $92,676 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-20 |
| Q1 FY2026Period ended 2026-03-31 | $92,700 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-02 |
| Q2 FY2026Period ended 2026-06-30 | $868,909 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $1,416,220 |
Current P/S: $60,537 market capitalization ÷ $1,416,220 TTM revenue = 0.04x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T14:15:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $868909.00.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 10 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:16:19.818Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|
| Non-US | $30M | $132,492 | $73,451 |
| UNITED STATES | $8M | $323,313 | $1M |
$1.42M
$1.42 Million
N/A
(33.57%)
5 Year compound annual growth rate
1 Year
N/A
3 Year
(68.18%)
5 Year
(33.57%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.29M | +$832,731 | +182.69% |
| 2024 | $455,805 | ($37.86M) | (98.81%) |
| 2023 | $38.32M | ($16.84M) | (30.53%) |
| 2022 | $55.15M | +$15.95M | +40.68% |
| 2021 | $39.20M | +$29.25M | +293.83% |
TTM Growth
N/A
3-Year CAGR
(68.18%)
5-Year CAGR
(33.57%)
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:16:19.818Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
